MyAverix Finance
SW · Healthcare
PolyPeptide Group AG (PPGN)
Drug Manufacturers - Specialty & Generic
PolyPeptide Group AG (PPGN) is listed on SW in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-24, reported market cap is $1.26B, P/E ratio is 18.00, net margin is -5.4%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PPGN
PolyPeptide Group AG (PPGN) — FAQ
What is PolyPeptide Group AG's market cap?
PolyPeptide Group AG (PPGN) has a reported market cap of $1.26B (data as of 2026-05-24).
What is PPGN's P/E ratio?
The price-to-earnings (P/E) ratio for PolyPeptide Group AG (PPGN) is 18.00 (data as of 2026-05-24).
Does PolyPeptide Group AG pay a dividend?
Dividend yield is not available in the current snapshot for PolyPeptide Group AG (PPGN). Check the MyAverix Finance app for the latest dividend data.
What sector is PolyPeptide Group AG in?
PolyPeptide Group AG (PPGN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is PPGN listed on?
PPGN is listed on SW.
What is PolyPeptide Group AG's net margin?
PolyPeptide Group AG (PPGN) reports a net margin of -5.4% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.